Skip to main content
Erschienen in: Abdominal Radiology 3/2017

22.10.2016

Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology

verfasst von: Daniel I. Glazer, Elmira Hassanzadeh, Andriy Fedorov, Olutayo I. Olubiyi, Shayna S. Goldberger, Tobias Penzkofer, Trevor A. Flood, Paul Masry, Robert V. Mulkern, Michelle S. Hirsch, Clare M. Tempany, Fiona M. Fennessy

Erschienen in: Abdominal Radiology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine if tumor cell density and percentage of Gleason pattern within an outlined volumetric tumor region of interest (TROI) on whole-mount pathology (WMP) correlate with apparent diffusion coefficient (ADC) values on corresponding TROIs outlined on pre-operative MRI.

Methods

Men with biopsy-proven prostate adenocarcinoma undergoing multiparametric MRI (mpMRI) prior to prostatectomy were consented to this prospective study. WMP and mpMRI images were viewed using 3D Slicer and each TROI from WMP was contoured on the high b-value ADC maps (b0, 1400). For each TROI outlined on WMP, TCD (tumor cell density) and the percentage of Gleason pattern 3, 4, and 5 were recorded. The ADCmean, ADC10th percentile, ADC90th percentile, and ADCratio were also calculated in each case from the ADC maps using 3D Slicer.

Results

Nineteen patients with 21 tumors were included in this study. ADCmean values for TROIs were 944.8 ± 327.4 vs. 1329.9 ± 201.6 mm2/s for adjacent non-neoplastic prostate tissue (p < 0.001). ADCmean, ADC10th percentile, and ADCratio values for higher grade tumors were lower than those of lower grade tumors (mean 809.71 and 1176.34 mm2/s, p = 0.014; 10th percentile 613.83 and 1018.14 mm2/s, p = 0.009; ratio 0.60 and 0.94, p = 0.005). TCD and ADCmean (ρ = −0.61, p = 0.005) and TCD and ADC10th percentile (ρ = −0.56, p = 0.01) were negatively correlated. No correlation was observed between percentage of Gleason pattern and ADC values.

Conclusion

DWI MRI can characterize focal prostate cancer using ADCratio, ADC10th percentile, and ADCmean, which correlate with pathological tumor cell density.
Literatur
1.
Zurück zum Zitat Cancer Facts & Figures (2016) American Cancer Society, Atlanta Cancer Facts & Figures (2016) American Cancer Society, Atlanta
2.
Zurück zum Zitat Wilt TJ, Brawer MK, Jones KM, et al. (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367(3):203–213CrossRefPubMedPubMedCentral Wilt TJ, Brawer MK, Jones KM, et al. (2012) Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 367(3):203–213CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Hamdy FC, Donovan JL, Lane JA, et al. (2016) 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med . doi:10.1056/NEJMoa1606221 Hamdy FC, Donovan JL, Lane JA, et al. (2016) 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med . doi:10.​1056/​NEJMoa1606221
4.
Zurück zum Zitat Dinh KT, Mahal BA, Ziehr DR, et al. (2015) Incidence and predictors of upgrading and up staging among 10,000 contemporary patients with low risk prostate cancer. J Urol 194(2):343–349CrossRefPubMed Dinh KT, Mahal BA, Ziehr DR, et al. (2015) Incidence and predictors of upgrading and up staging among 10,000 contemporary patients with low risk prostate cancer. J Urol 194(2):343–349CrossRefPubMed
5.
Zurück zum Zitat Dinh KT, Muralidhar V, Mahal BA, et al. (2015) Occult high-risk disease in clinically low-risk prostate cancer with ≥50% positive biopsy cores: should national guidelines stop calling them low-risk? Urology . doi:10.1016/j.urology.2015.08.026 PubMed Dinh KT, Muralidhar V, Mahal BA, et al. (2015) Occult high-risk disease in clinically low-risk prostate cancer with ≥50% positive biopsy cores: should national guidelines stop calling them low-risk? Urology . doi:10.​1016/​j.​urology.​2015.​08.​026 PubMed
6.
Zurück zum Zitat Barry MJ, Gallagher PM, Skinner JS, Fowler FJ (2012) Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol 30(5):513–518CrossRefPubMedPubMedCentral Barry MJ, Gallagher PM, Skinner JS, Fowler FJ (2012) Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. J Clin Oncol 30(5):513–518CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ploussard G, Epstein JI, Montironi R, et al. (2011) The contemporary concept of significant versus insignificant prostate cancer. Eur Urol 60(2):291–303CrossRefPubMed Ploussard G, Epstein JI, Montironi R, et al. (2011) The contemporary concept of significant versus insignificant prostate cancer. Eur Urol 60(2):291–303CrossRefPubMed
8.
Zurück zum Zitat Stark JR, Perner S, Stampfer MJ, et al. (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27(21):3459–3464CrossRefPubMedPubMedCentral Stark JR, Perner S, Stampfer MJ, et al. (2009) Gleason score and lethal prostate cancer: does 3 + 4 = 4 + 3? J Clin Oncol 27(21):3459–3464CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243(1):28–53CrossRefPubMed Hricak H, Choyke PL, Eberhardt SC, Leibel SA, Scardino PT (2007) Imaging prostate cancer: a multidisciplinary perspective. Radiology 243(1):28–53CrossRefPubMed
10.
Zurück zum Zitat Turkbey B, Brown AM, Sankineni S, et al. (2015) Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin 40(7):2557–2565 Turkbey B, Brown AM, Sankineni S, et al. (2015) Multiparametric prostate magnetic resonance imaging in the evaluation of prostate cancer. CA Cancer J Clin 40(7):2557–2565
11.
Zurück zum Zitat Glazer DI, Davenport MS, Khalatbari S, et al. (2015) Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer. Abdom Imaging 40(3):560–570CrossRefPubMed Glazer DI, Davenport MS, Khalatbari S, et al. (2015) Mass-like peripheral zone enhancement on CT is predictive of higher-grade (Gleason 4 + 3 and higher) prostate cancer. Abdom Imaging 40(3):560–570CrossRefPubMed
14.
Zurück zum Zitat Ankerst DP, Hoefler J, Bock S, et al. (2014) Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology 83(6):1362–1367CrossRefPubMedPubMedCentral Ankerst DP, Hoefler J, Bock S, et al. (2014) Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs high-grade prostate cancer. Urology 83(6):1362–1367CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Kweldam CF, Wildhagen MF, Steyerberg EW, et al. (2015) Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Mod Pathol 28(3):457–464CrossRefPubMed Kweldam CF, Wildhagen MF, Steyerberg EW, et al. (2015) Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer. Mod Pathol 28(3):457–464CrossRefPubMed
16.
Zurück zum Zitat Dong F, Yang P, Wang C, et al. (2013) Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma. Am J Surg Pathol 37(12):1855–1861CrossRefPubMed Dong F, Yang P, Wang C, et al. (2013) Architectural heterogeneity and cribriform pattern predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma. Am J Surg Pathol 37(12):1855–1861CrossRefPubMed
17.
Zurück zum Zitat Radtke JP, Schwab C, Wolf MB, et al. (2016) Multiparametric magnetic resonance imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen. Eur Urol . doi:10.1016/j.eururo.2015.12.052 Radtke JP, Schwab C, Wolf MB, et al. (2016) Multiparametric magnetic resonance imaging (MRI) and MRI-transrectal ultrasound fusion biopsy for index tumor detection: correlation with radical prostatectomy specimen. Eur Urol . doi:10.​1016/​j.​eururo.​2015.​12.​052
18.
Zurück zum Zitat Delongchamps NB, Lefèvre A, Bouazza N, et al. (2015) Detection of significant prostate cancer with magnetic resonance targeted biopsies–should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? J Urol 193(4):1198–1204CrossRefPubMed Delongchamps NB, Lefèvre A, Bouazza N, et al. (2015) Detection of significant prostate cancer with magnetic resonance targeted biopsies–should transrectal ultrasound-magnetic resonance imaging fusion guided biopsies alone be a standard of care? J Urol 193(4):1198–1204CrossRefPubMed
19.
Zurück zum Zitat Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS Prostate Imaging–Reporting and Data System: 2015, Version 2. Eur Urol 69(1):16–40CrossRefPubMed Weinreb JC, Barentsz JO, Choyke PL, et al. (2016) PI-RADS Prostate Imaging–Reporting and Data System: 2015, Version 2. Eur Urol 69(1):16–40CrossRefPubMed
20.
Zurück zum Zitat Vargas HA, Akin O, Franiel T, et al. (2011) Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259(3):775–784CrossRefPubMedPubMedCentral Vargas HA, Akin O, Franiel T, et al. (2011) Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 259(3):775–784CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Kim TH, Jeong JY, Lee SW, et al. (2015) Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance. Eur Radiol 25(6):1786–1792CrossRefPubMed Kim TH, Jeong JY, Lee SW, et al. (2015) Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance. Eur Radiol 25(6):1786–1792CrossRefPubMed
22.
Zurück zum Zitat Boesen L, Chabanova E, Løgager V, Balslev I, Thomsen HS (2015) Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology. J Magn Reson Imaging 42(2):446–453CrossRefPubMed Boesen L, Chabanova E, Løgager V, Balslev I, Thomsen HS (2015) Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology. J Magn Reson Imaging 42(2):446–453CrossRefPubMed
23.
Zurück zum Zitat Hambrock T, Somford DM, Huisman HJ, et al. (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259(2):453–461CrossRefPubMed Hambrock T, Somford DM, Huisman HJ, et al. (2011) Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer. Radiology 259(2):453–461CrossRefPubMed
24.
Zurück zum Zitat Mazaheri Y, Shukla-Dave A, Hricak H, et al. (2008) Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging—correlation with pathologic findings. Radiology 246(2):480–488CrossRefPubMed Mazaheri Y, Shukla-Dave A, Hricak H, et al. (2008) Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging—correlation with pathologic findings. Radiology 246(2):480–488CrossRefPubMed
25.
Zurück zum Zitat Oto A, Kayhan A, Jiang Y, et al. (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723CrossRefPubMed Oto A, Kayhan A, Jiang Y, et al. (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 257(3):715–723CrossRefPubMed
26.
Zurück zum Zitat Donati OF, Mazaheri Y, Afaq A, et al. (2014) Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 271(1):143–152CrossRefPubMed Donati OF, Mazaheri Y, Afaq A, et al. (2014) Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 271(1):143–152CrossRefPubMed
27.
Zurück zum Zitat Rosenkrantz AB, Triolo MJ, Melamed J, et al. (2015) Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy. J Magn Reson Imaging 41(3):708–714CrossRefPubMed Rosenkrantz AB, Triolo MJ, Melamed J, et al. (2015) Whole-lesion apparent diffusion coefficient metrics as a marker of percentage Gleason 4 component within Gleason 7 prostate cancer at radical prostatectomy. J Magn Reson Imaging 41(3):708–714CrossRefPubMed
28.
Zurück zum Zitat Fedorov A, Penzkofer T, Hirsch MS, et al. (2015) The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI. Acad Radiol 22(5):548–555CrossRefPubMedPubMedCentral Fedorov A, Penzkofer T, Hirsch MS, et al. (2015) The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI. Acad Radiol 22(5):548–555CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Fennessy FM, Fedorov A, Penzkofer T, et al. (2015) Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging 33(7):886–894CrossRefPubMedPubMedCentral Fennessy FM, Fedorov A, Penzkofer T, et al. (2015) Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging 33(7):886–894CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Hegde JV, Mulkern RV, Panych LP, et al. (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37(5):1035–1054CrossRefPubMedPubMedCentral Hegde JV, Mulkern RV, Panych LP, et al. (2013) Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer. J Magn Reson Imaging 37(5):1035–1054CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Trivedi H, Turkbey B, Rastinehad AR, et al. (2012) Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology 79(1):233–239CrossRefPubMedPubMedCentral Trivedi H, Turkbey B, Rastinehad AR, et al. (2012) Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology 79(1):233–239CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30(9):1323–1341CrossRefPubMedPubMedCentral Fedorov A, Beichel R, Kalpathy-Cramer J, et al. (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30(9):1323–1341CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Jonmarker S, Valdman A, Lindberg A, Hellström M, Egevad L (2006) Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch 449(3):297–301CrossRefPubMed Jonmarker S, Valdman A, Lindberg A, Hellström M, Egevad L (2006) Tissue shrinkage after fixation with formalin injection of prostatectomy specimens. Virchows Arch 449(3):297–301CrossRefPubMed
34.
Zurück zum Zitat Stamey TA, Freiha FS, McNeal JE, et al. (1993) Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(3 Suppl):933–938CrossRefPubMed Stamey TA, Freiha FS, McNeal JE, et al. (1993) Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(3 Suppl):933–938CrossRefPubMed
35.
Zurück zum Zitat Wolters T, Roobol MJ, van Leeuwen PJ, et al. (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185(1):121–125CrossRefPubMed Wolters T, Roobol MJ, van Leeuwen PJ, et al. (2011) A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. J Urol 185(1):121–125CrossRefPubMed
36.
Zurück zum Zitat Kuwano H, Miyazaki T, Tsutsumi S, et al. (2004) Cell density modulates the metastatic aggressiveness of a mouse colon cancer cell line, colon 26. Oncology 67(5–6):441–449PubMed Kuwano H, Miyazaki T, Tsutsumi S, et al. (2004) Cell density modulates the metastatic aggressiveness of a mouse colon cancer cell line, colon 26. Oncology 67(5–6):441–449PubMed
37.
Zurück zum Zitat Pernicová Z, Slabáková E, Fedr R, et al. (2014) The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells. Mol Cancer 13:113CrossRefPubMedPubMedCentral Pernicová Z, Slabáková E, Fedr R, et al. (2014) The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells. Mol Cancer 13:113CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Tollefson MK, Leibovich BC, Slezak JM, Zincke H, Blute ML (2006) Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol 175(2):547–551CrossRefPubMed Tollefson MK, Leibovich BC, Slezak JM, Zincke H, Blute ML (2006) Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survival. J Urol 175(2):547–551CrossRefPubMed
39.
Zurück zum Zitat Vargas HA, Hötker AM, Goldman DA, et al. (2015) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol . doi:10.1007/s00330-015-4015-6 Vargas HA, Hötker AM, Goldman DA, et al. (2015) Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical evaluation using whole-mount pathology as standard of reference. Eur Radiol . doi:10.​1007/​s00330-015-4015-6
40.
Zurück zum Zitat Gibbs P, Liney GP, Pickles MD, et al. (2009) Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Investig Radiol 44(9):572–576CrossRef Gibbs P, Liney GP, Pickles MD, et al. (2009) Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla. Investig Radiol 44(9):572–576CrossRef
41.
Zurück zum Zitat Zelhof B, Pickles M, Liney G, et al. (2009) Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 103(7):883–888CrossRefPubMed Zelhof B, Pickles M, Liney G, et al. (2009) Correlation of diffusion-weighted magnetic resonance data with cellularity in prostate cancer. BJU Int 103(7):883–888CrossRefPubMed
42.
Zurück zum Zitat Chatterjee A, Watson G, Myint E, et al. (2015) Changes in epithelium, stroma, and lumen space correlate more strongly with Gleason Pattern and are stronger predictors of prostate ADC changes than cellularity metrics. Radiology 277(3):751–762CrossRefPubMed Chatterjee A, Watson G, Myint E, et al. (2015) Changes in epithelium, stroma, and lumen space correlate more strongly with Gleason Pattern and are stronger predictors of prostate ADC changes than cellularity metrics. Radiology 277(3):751–762CrossRefPubMed
43.
Zurück zum Zitat Bollineni VR, Kramer G, Liu Y, Melidis C, deSouza NM (2015) A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer. Cancer Treat Rev 41(6):496–502CrossRefPubMed Bollineni VR, Kramer G, Liu Y, Melidis C, deSouza NM (2015) A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer. Cancer Treat Rev 41(6):496–502CrossRefPubMed
44.
Zurück zum Zitat Turkbey B, Shah VP, Pang Y, et al. (2011) Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258(2):488–495CrossRefPubMedPubMedCentral Turkbey B, Shah VP, Pang Y, et al. (2011) Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 258(2):488–495CrossRefPubMedPubMedCentral
Metadaten
Titel
Diffusion-weighted endorectal MR imaging at 3T for prostate cancer: correlation with tumor cell density and percentage Gleason pattern on whole mount pathology
verfasst von
Daniel I. Glazer
Elmira Hassanzadeh
Andriy Fedorov
Olutayo I. Olubiyi
Shayna S. Goldberger
Tobias Penzkofer
Trevor A. Flood
Paul Masry
Robert V. Mulkern
Michelle S. Hirsch
Clare M. Tempany
Fiona M. Fennessy
Publikationsdatum
22.10.2016
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 3/2017
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-016-0942-1

Weitere Artikel der Ausgabe 3/2017

Abdominal Radiology 3/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.